ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,954.50
      1.59%
      US Tech 100
      20,332.80
      1.61%
      Dow Jones
      43,840.91
      1.39%
      Brent Oil
      73.045
      0.00%
      Bitcoin
      92,851.66
      7.92%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Clearside Biomedical Inc (CLSD) Quote

      Clearside Biomedical Inc

      Clearside Biomedical Inc (CLSD)

      NASDAQ
      0.8597
      -0.029
      (-3.26%)
      Closed March 02 4:00PM
      Delayed by 15 minutes
      0.85
      -0.0097
      (-1.13%)
      After Hours: 7:46PM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      0.85
      Bid
      0.84
      Ask
      1.92
      Volume
      244,296
      0.85 Day's Range 0.899
      0.801 52 Week Range 2.12
      Market Cap
      64.467M
      Previous Close
      0.8887
      Open
      0.871
      Last Trade
      2424
      @
      0.85
      (formt)
      Last Trade Time
      Financial Volume
      $ 213,303
      VWAP
      0.873132
      Average Volume (3m)
      245,478
      Shares Outstanding
      75,843,504
      Dividend Yield
      -
      PE Ratio
      -2.01
      Earnings Per Share (EPS)
      -0.43
      Revenue
      8.23M
      Net Profit
      -32.49M

      About Clearside Biomedical Inc

      Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye. The product candidates of the company focus on a disease affecting the retina and aim to restore or improve visual functio... Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye. The product candidates of the company focus on a disease affecting the retina and aim to restore or improve visual function primarily by reducing the macular edema associated with several diseases affecting vision. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.clearsidebio.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Clearside Biomedical Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CLSD. The last closing price for Clearside Biomedical was $0.89. Over the last year, Clearside Biomedical shares have traded in a share price range of $ 0.801 to $ 2.12.

      Clearside Biomedical currently has 75,843,504 shares outstanding. The market capitalization of Clearside Biomedical is $67.40 million. Clearside Biomedical has a price to earnings ratio (PE ratio) of -2.01.

      Ask ADVFN Intelligence (AI)

      CLSD Latest News

      More News

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      February 24 2025
      CLSD (-3.26%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      February 13 2025
      CLSD (-3.26%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      January 10 2025
      CLSD (-3.26%)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.17-16.66666666671.021.020.852284060.90522938CS
      4-0.09-9.574468085110.941.140.852341081.01755047CS
      12-0.2-19.04761904761.051.140.8012454780.97471046CS
      26-0.17-16.66666666671.021.650.8014932741.18030085CS
      52-0.51-37.51.362.120.8013887871.265259CS
      156-0.72-45.85987261151.572.850.6501013103821.45074527CS
      260-1.13-57.07070707071.987.730.6501015012022.96558735CS

      CLSD - Frequently Asked Questions (FAQ)

      What is the current Clearside Biomedical share price?
      The current share price of Clearside Biomedical is $ 0.85
      How many Clearside Biomedical shares are in issue?
      Clearside Biomedical has 75,843,504 shares in issue
      What is the market cap of Clearside Biomedical?
      The market capitalisation of Clearside Biomedical is USD 67.4M
      What is the 1 year trading range for Clearside Biomedical share price?
      Clearside Biomedical has traded in the range of $ 0.801 to $ 2.12 during the past year
      What is the PE ratio of Clearside Biomedical?
      The price to earnings ratio of Clearside Biomedical is -2.01
      What is the cash to sales ratio of Clearside Biomedical?
      The cash to sales ratio of Clearside Biomedical is 7.93
      What is the reporting currency for Clearside Biomedical?
      Clearside Biomedical reports financial results in USD
      What is the latest annual turnover for Clearside Biomedical?
      The latest annual turnover of Clearside Biomedical is USD 8.23M
      What is the latest annual profit for Clearside Biomedical?
      The latest annual profit of Clearside Biomedical is USD -32.49M
      What is the registered address of Clearside Biomedical?
      The registered address for Clearside Biomedical is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
      What is the Clearside Biomedical website address?
      The website address for Clearside Biomedical is www.clearsidebio.com
      Which industry sector does Clearside Biomedical operate in?
      Clearside Biomedical operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      STAKSTAK Inc
      $ 3.97
      (156.13%)
      		174.23k
      ORGOOrganogenesis Holdings Inc
      $ 6.21
      (102.28%)
      		59M
      TRNRInteractive Strength Inc
      $ 2.57
      (67.97%)
      		193.57M
      PMAXPowell Max Ltd
      $ 0.511
      (43.54%)
      		137.18M
      ARBBARB IOT Group Ltd
      $ 0.6635
      (38.23%)
      		59.08M
      NVNINVNI Group Ltd
      $ 0.99
      (-50.50%)
      		72.79M
      SPGCSacks Parente Golf Inc
      $ 0.2085
      (-48.65%)
      		58.21M
      ADGMAdagio Medical Holdings Inc
      $ 0.8081
      (-47.53%)
      		756.76k
      PRAXPraxis Precision Medicines Inc
      $ 38.60
      (-40.64%)
      		3.2M
      SAGSAG Holdings Ltd
      $ 1.19
      (-38.97%)
      		789.86k
      NVDANVIDIA Corporation
      $ 124.92
      (3.97%)
      		389.48M
      TRNRInteractive Strength Inc
      $ 2.57
      (67.97%)
      		193.57M
      TSLLDirexion Daily TSLA Bull 2X Trust ETF
      $ 13.44
      (7.78%)
      		154.46M
      PMAXPowell Max Ltd
      $ 0.511
      (43.54%)
      		137.18M
      LCIDLucid Group Inc
      $ 2.22
      (-0.45%)
      		136.17M

      CLSD Discussion

      View Posts
      BBANBOB BBANBOB 3 weeks ago
      HMMMMMMMMMMMMMMMM 1.05
      šŸ‘ļø0
      findit findit 4 weeks ago
      Posted to wrong board. Just deleted it.
      šŸ‘ļø0
      georgie18 georgie18 4 weeks ago
      ???
      šŸ‘ļø0
      findit findit 4 weeks ago
      Delete
      šŸ‘ļø0
      georgie18 georgie18 2 months ago
      CLSD...95...🥳...Setting up for $1.20 Break...imo...we shall see... https://schrts.co/nhFdXepw

      CLSD...$1.45...🥳...ALPHARETTA, Ga., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that the ODYSSEY Phase 2b clinical trial of CLS-AX (axitinib injectable suspension) for the treatment of neovascular age-related macular degeneration (wet AMD) achieved both its primary and secondary outcomes. In participants who received CLS-AX delivered suprachoroidally, best corrected visual acuity (BCVA) and ocular anatomy (central subfield thickness) were stable up to 6 months compared to participants who received aflibercept. In addition, CLS-AX demonstrated a well-tolerated safety profile to Week 36 inclusive of mandatory re-dosing of CLS-AX at Week 24.
      šŸ‘ļø0
      Invest-in-America Invest-in-America 5 months ago
      CLSD: Nice news for sure, but heavy FLOAT of 63-million..
      šŸ‘ļø0
      Awl416 Awl416 5 months ago
      Clearside Biomedical Announces Positive Topline Results from ODYSSEY Phase 2b Trial of Suprachoroidal CLS-AX in Wet AMD Achieving All Primary and Secondary Outcomes
      šŸ‘ļø0
      BBANBOB BBANBOB 5 months ago
      CLSD 1.52
      šŸ‘ļø0
      BBANBOB BBANBOB 6 months ago
      CLSD under 1$ @ .9355
      šŸ‘ļø0
      Monksdream Monksdream 6 months ago
      CLSD under $2
      šŸ‘ļø0
      Monksdream Monksdream 8 months ago
      CLSD under $2
      šŸ‘ļø0
      Monksdream Monksdream 10 months ago
      CLSD under $2
      šŸ‘ļø0
      BBANBOB BBANBOB 11 months ago
      I'll suggest now that the GAP FILLED yesterday and it takes news 2-3 days to be digested, tomorrow we hopefully head back to the 2$ area, just my WAG bwthdik
      šŸ‘ļø0
      BBANBOB BBANBOB 12 months ago
      WHO KNOWS PARD WHO KNOWS
      👍️ 1
      BBANBOB BBANBOB 12 months ago
      .
      šŸ‘ļø0
      jhdf51 jhdf51 12 months ago
      Great..well maybe just maybe we are finally on our way albeit perhaps a bumpy ride...

      JHD
      šŸ‘ļø0
      BBANBOB BBANBOB 12 months ago
      JHD

      NOT really GAP filled and has held up very well, next surge is on its way and still say this will close on FRI over $2

      Vol is holding UPPPPPPPP well so, something is up here, from 2.12 to 1.47 was a major head fake to close the gap imho and probably casue a lot to part with some shares WHIH imho is exactly what they wanted...............
      šŸ‘ļø0
      jhdf51 jhdf51 12 months ago
      Same ol same ol
      šŸ‘ļø0
      BBANBOB BBANBOB 12 months ago
      WE BOTH HAVE THE SAME PROBLEM

      DNDN been there done that and not again
      👍️ 1
      BBANBOB BBANBOB 12 months ago
      .53 cent loss versus .55 loss last yr
      šŸ‘ļø0
      jhdf51 jhdf51 12 months ago
      Yep..I was thinking of getting out but same...
      šŸ‘ļø0
      BBANBOB BBANBOB 12 months ago
      Not REAL THRILLED with the earnings to be released AH's that is normally indicative of bad numbers, so looks like the 2.12 was a head fake for some to get out
      I came close to selling 50% yesterday and get back in when it closes the gap @ 1.54,,,,,,, but just couldn't find the CAJONES to do it..........OH WELL NO BALLS NO BLACK CHIPS
      šŸ‘ļø0
      BBANBOB BBANBOB 12 months ago
      Appears they are playing this real hard to get shares all the way to 1.81 from 2.12
      šŸ‘ļø0
      BBANBOB BBANBOB 12 months ago
      1.87 NEW annual high and HOD. 3 trade days ago we did 3 mill shares and VOL proceeds PPS

      MY WAG is this is over 2$ by weeks end.

      AND NO not pumping this since I have held it for over 2 yrs NOV of 2022 and @ $4.86 finally got my avg to $2.00
      šŸ‘ļø0
      Monksdream Monksdream 12 months ago
      CLSD 10Q due March 12
      šŸ‘ļø0
      Monksdream Monksdream 12 months ago
      CLSD new 52 week hi
      šŸ‘ļø0
      glenn1919 glenn1919 12 months ago
      CLSD....................................................https://stockcharts.com/h-sc/ui?s=CLSD&p=W&b=5&g=0&id=p86431144783
      šŸ‘ļø0
      BBANBOB BBANBOB 12 months ago
      And on VERY GOOD VOL, me thinks something is up
      šŸ‘ļø0
      Monksdream Monksdream 12 months ago
      CLSD new 52 week high
      šŸ‘ļø0
      Monksdream Monksdream 1 year ago
      CLSD under $2
      šŸ‘ļø0
      BBANBOB BBANBOB 1 year ago
      OOOOOOOOOOOOOPS $1.47
      šŸ‘ļø0
      BBANBOB BBANBOB 1 year ago
      OPPPPPPPPPPPPPPS .6951
      šŸ‘ļø0
      BBANBOB BBANBOB 1 year ago
      APPEARS we just made a new one too DAMN @ .70

      I'm hoping they are tanking it in front of good earning to pick it up I KNOWWWWWWWWWWWWWWWWWWWWWWWWWWWW
      šŸ‘ļø0
      Monksdream Monksdream 1 year ago
      CLSD new 52 week low
      šŸ‘ļø0
      Monksdream Monksdream 1 year ago
      CLSD new 52 week low
      šŸ‘ļø0
      Monksdream Monksdream 1 year ago
      CLSD new 52 week low
      šŸ‘ļø0
      Monksdream Monksdream 1 year ago
      CLSD new 52 week low
      šŸ‘ļø0
      heyitsmeagain heyitsmeagain 3 years ago
      Here we go
      šŸ‘ļø0
      heyitsmeagain heyitsmeagain 3 years ago
      Loaded for this runner. Wish I had more loot.
      šŸ‘ļø0
      BBANBOB BBANBOB 3 years ago
      Hard to Borrow is back on CLSD today
      šŸ‘ļø0
      BBANBOB BBANBOB 3 years ago
      FYI

      THE HARD TO BORROW classification(at Schwab) just went POOF GHONDI as of today on CLSD and at the same time its is up 3.81%

      HMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMM
      šŸ‘ļø0
      BBANBOB BBANBOB 3 years ago
      Well so far so good !!!!!!!!!!!!!!!!!! Let's say for grins $3 on Fri
      šŸ‘ļø0
      BBANBOB BBANBOB 3 years ago
      Well well let's give this news 2-3 days to digest and see where it is by weeks end.

      Also if if if this is gonna take off as I believe, the first part of the week MIGHT JUST SCARE THE WEAK here.

      If you're faint at heart or can't handle pressure, one might want to JUST NOT LOOK for the next few days
      šŸ‘ļø0
      jhdf51 jhdf51 3 years ago
      Now that would be perfect. Iā€™d hire me a farm hand, or two, or three! Lol

      JHD
      šŸ‘ļø0
      BBANBOB BBANBOB 3 years ago
      Again

      Earnings was a beat and they were .31 for the LAST quarter PER SHARE, do that X's a whole yr and then X's a multiple of 10-12 and there ya have it.

      NOW Since this appears to be JUST the start of licensing, who knows how many more licenses will be entered into in the next year.

      MY PPS prediction would be along the lines of $27-$35 in the next 12 months WAG and IMHO
      šŸ‘ļø0
      jhdf51 jhdf51 3 years ago
      Yes I agree. Definitely could be. Dang Price targets are never exact anyway.
      šŸ‘ļø0
      BBANBOB BBANBOB 3 years ago
      I'll take $9 for this year, but still say it will be more.
      šŸ‘ļø0
      jhdf51 jhdf51 3 years ago
      I see $9. $18 was last year.

      https://www.google.com/amp/s/www.marketbeat.com/instant-alerts/nasdaq-clsd-a-buy-or-sell-right-now-2022-03-2/amp/
      šŸ‘ļø0
      BBANBOB BBANBOB 3 years ago
      But all companies good or bad always have HEDGE FUNDS that short their stock, THUS the meaning of HEDGE, being on both sides of the trade, much like a BOOKIE taking sports bets will take EITHER SIDE of a bet.

      BUT unlike a bookie that takes your bet and at half time IS WAY UPSIDE down on the bet he made with you, HE DOES NOT HAVE THE OPPORTUNITY to CHANGE his bet, SHORTS DO at any given time

      THUNK ABOUT IT BOYZZZZZZZZZZZ
      šŸ‘ļø0
      BBANBOB BBANBOB 3 years ago
      SHORTS

      Again as I did last week, I would serious suggest that you close even the few shorts you have still open here, as it might get REAL NASTY if ya don't, JUST SAYING
      šŸ‘ļø0

      Your Recent History

      NASDAQ
      CLSD
      Clearside Biomedical
      BIT
      I08125
      Intesa Sanpaolo
      BIT
      1BBY
      Best Buy
      NASDAQ
      FDMNX
      Bmo Global Equity Fund A...
      NASDAQ
      GSHD
      Goosehead Insurance
      COIN
      ENXUST
      ENEX.SPACE
      NASDAQ
      GPCB
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads